S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
Novo Nordisk Arms Wegovy to Be a Triple Threat
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
Novo Nordisk Arms Wegovy to Be a Triple Threat
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
Novo Nordisk Arms Wegovy to Be a Triple Threat
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
Novo Nordisk Arms Wegovy to Be a Triple Threat
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?

PharmaCyte Biotech (PMCB) Earnings Date, Estimates & Call Transcripts

$2.11
-0.12 (-5.38%)
(As of 04/15/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Jul. 29Estimated
Actual EPS
(Mar. 18)
-$0.65 Missed By -$0.65
Skip Charts & View Estimated and Actual Earnings Data

PMCB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PMCB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

PMCB Earnings Date and Information

PharmaCyte Biotech last announced its earnings data on March 18th, 2024. The reported ($0.65) earnings per share (EPS) for the quarter. PharmaCyte Biotech has generated ($1.20) earnings per share over the last year (($1.20) diluted earnings per share). PharmaCyte Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 29th, 2024 based off prior year's report dates.

PharmaCyte Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/29/2024
Estimated)
------- 
3/18/2024Q3 2024-($0.65)($0.65)($0.65)--
12/15/2023Q2 2024-($0.64)($0.64)($1.02)--
9/18/2023Q1 2024-($0.28)($0.28)($0.28)--
7/31/2023Q4 2023-($0.01)($0.01)($0.01)--
3/16/2023Q3 2023-($0.04)($0.04)($0.04)--
12/14/2022Q2 2023-($0.09)($0.09)($0.09)--
9/14/2022Q1 2023($0.07)($0.07)-($0.07)--
7/28/2022Q4 2022-($0.06)($0.06)($0.06)--
3/15/2022Q3 2022($0.05)($0.04)+$0.01($0.04)--
12/15/2021Q2($0.07)($0.06)+$0.01($0.06)--
9/14/2021Q1 2022-($0.64)($0.64)($0.64)--

PharmaCyte Biotech Earnings - Frequently Asked Questions

When is PharmaCyte Biotech's earnings date?

PharmaCyte Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 29th, 2024 based off last year's report dates. Learn more on PMCB's earnings history.

How much profit does PharmaCyte Biotech generate each year?

PharmaCyte Biotech (NASDAQ:PMCB) has a recorded net income of -$4.32 million. PMCB has generated -$1.20 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:PMCB) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners